Travera was founded in 2017 to commercialize a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT).
The company’s initial test is based on this technology; a new measurement tool called the Suspended Microchannel Resonator (SMR) that makes exquisitely precise measurements of the effects of cancer drugs on cancer cells.
Travera’s leadership team is comprised of experienced business executives and researchers who are responsible for defining and implementing the company’s strategy to offer a test which provides physicians and their patients a personalized approach to cancer treatment .
Grey Sky Venture Partners
Grey Sky Venture Partners focuses on discovering and funding exceptional management teams developing compelling, well-protected innovations springing from leading-edge research that have the potential to significantly impact the complex and rapidly changing healthcare system.
We make early-stage investments in healthcare and medical technology companies that seek to improve clinical outcomes, enhance quality of life, or reduce system costs. With a heritage rooted in invention, Grey Sky also brings intellectual property expertise and access to a patent portfolio that can be strategically valuable to young companies.
For more information please visit www.gsvp.com.
The Leukemia and Lymphoma Society
The Leukemia & Lymphoma Society is at the forefront of the fight to cure cancer. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested nearly $1.3 billion in groundbreaking research, pioneering many of today’s most innovative approaches.
For more information please visit www.lls.org.
Altru Institute is a philanthropic think tank that supports organizations addressing global humanitarian challenges. We aggregate, curate, and convene leading thinkers, fostering industry collaboration to increase the efficiency and performance of individual organizations. As part of our mission to connect individuals and small companies that are addressing global humanitarian challenges, we manage the Travera Special Purpose Vehicle (SPV), enabling investors to support Travera in their mission to improve care for cancer patients.
For more information please visit www.altruinstitute.com.